Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Nano Mask Seals Agreement With Wein Products

To distribute Wein Products' respirators

Nano Mask has entered into a three year agreement with Wein Products to distribute that company’s products as it continues to complete the development of its own proprietary disposable NanoMask respirator and to obtain regulatory approval for the NanoMask. The company has begun shipping orders of the Wein Products respirators.

Reportedly, Nano Mask has already entered into an agreement with a medical products company in Turkey to represent the Wein Products respirators in the country.

The company has also signed a similar distribution agreement with a US medical products distributor and expects to enter into similar agreements with a number of additional US distributors. In addition, Nano Mask has held discussions with distributors in Asia and South America and hopes to enter into distribution agreements in the areas.

Doug Heath, president and CEO at Nano Mask, said: “Strong demand for disposable respirators has given rise to an opportunity for us to generate what we believe will be a strong revenue stream and, equally important, build a strong distribution network that we will be able to access for our NanoMask.

“We continue to make great strides in finalizing the development of the NanoMask and in formulating a strategy to obtain the requisite regulatory approvals needed to market our mask in Europe and the US.

Recently, the FDA and the European regulators have significantly tightened their regulatory standards in an effort to rid the marketplace of unscrupulous makers and marketers of respirators who have been making unsupportable claims in order to capitalise on the swine flu pandemic.

“This regulatory tightening has measurably slowed our regulatory application process. As a result, the opportunity to generate near term revenues while we finalise our own product offering was too great to forego.”